Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses - PubMed (original) (raw)
Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses
Lydie Trautmann et al. J Immunol. 2005.
Abstract
Assessment of clonal diversity of T cell responses against human CMV (HCMV), a major cause of morbidity in immunodepressed patients, provides important insights into the molecular basis of T cell immunodominance, and has also clinical implications for the immunomonitoring and immunotherapy of HCMV infections. We performed an in-depth molecular and functional characterization of CD8 T cells directed against an immunodominant HLA-A2-restricted epitope derived from HCMV protein pp65 (NLV/A2) in steady state and pathological situations associated with HCMV reactivation. NLV/A2-specific T cells in healthy HCMV-seropositive donors showed limited clonal diversity and usage of a restricted set of TCR Vbeta regions. Although TCRbeta-chain junctional sequences were highly diverse, a large fraction of NLV/A2-specific T cells derived from distinct individuals showed several recurrent (so-called "public") TCR features associated in some cases with full conservation of the TCRalpha chain junctional region. A dramatic clonal focusing of NLV/A2-specific T cells was observed in situations of HCMV reactivation and/or chronic inflammation, which resulted in selection of a single clonotype displaying similar public TCR features in several patients. In most instances the NLV/A2-specific dominant clonotypes showed higher affinity for their Ag than subdominant ones, thus suggesting that TCR affinity/avidity is the primary driving force underlying repertoire focusing along chronic antigenic stimulation.
Similar articles
- Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus.
Day EK, Carmichael AJ, ten Berge IJ, Waller EC, Sissons JG, Wills MR. Day EK, et al. J Immunol. 2007 Sep 1;179(5):3203-13. doi: 10.4049/jimmunol.179.5.3203. J Immunol. 2007. PMID: 17709536 - Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.
Peggs K, Verfuerth S, Pizzey A, Ainsworth J, Moss P, Mackinnon S. Peggs K, et al. Blood. 2002 Jan 1;99(1):213-23. doi: 10.1182/blood.v99.1.213. Blood. 2002. PMID: 11756174 - The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG. Wills MR, et al. J Virol. 1996 Nov;70(11):7569-79. doi: 10.1128/JVI.70.11.7569-7579.1996. J Virol. 1996. PMID: 8892876 Free PMC article. - Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope.
Yang X, Gao M, Chen G, Pierce BG, Lu J, Weng NP, Mariuzza RA. Yang X, et al. J Biol Chem. 2015 Nov 27;290(48):29106-19. doi: 10.1074/jbc.M115.691311. Epub 2015 Oct 1. J Biol Chem. 2015. PMID: 26429912 Free PMC article. Clinical Trial.
Cited by
- IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release.
Schardt JS, Walseng E, Le K, Yang C, Shah P, Fu Y, Alam K, Kelton CR, Gu Y, Huang F, Lin J, Liu W, Dippel A, Zhang H, Mulgrew K, Pryts S, Chennupati V, Chen HC, Denham J, Chen X, Pradhan P, Wu Y, Hardman C, Zhao C, Kierny M, Song Y, Dovedi SJ, Cemerski S, Mazor Y. Schardt JS, et al. MAbs. 2024 Jan-Dec;16(1):2395499. doi: 10.1080/19420862.2024.2395499. Epub 2024 Aug 28. MAbs. 2024. PMID: 39205483 Free PMC article. - The Memory-CD8+-T-Cell Response to Conserved Influenza Virus Epitopes in Mice Is Not Influenced by Time Since Previous Infection.
Lanfermeijer J, van de Ven K, Hendriks M, van Dijken H, Lenz S, Vos M, Borghans JAM, van Baarle D, de Jonge J. Lanfermeijer J, et al. Vaccines (Basel). 2024 Apr 15;12(4):419. doi: 10.3390/vaccines12040419. Vaccines (Basel). 2024. PMID: 38675801 Free PMC article. - The signature of a T-cell response to KSHV persists across space and time in individuals with epidemic and endemic KS from Uganda.
Ravishankar S, Towlerton AMH, Mooka P, Kafeero J, Coffey DG, Aicher LD, Mubiru KR, Okoche L, Atwinirembabazi P, Okonye J, Phipps WT, Warren EH. Ravishankar S, et al. bioRxiv [Preprint]. 2024 Feb 8:2024.02.06.579223. doi: 10.1101/2024.02.06.579223. bioRxiv. 2024. PMID: 38370623 Free PMC article. Preprint. - Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials.
Vantourout P, Eum J, Conde Poole M, Hayday TS, Laing AG, Hussain K, Nuamah R, Kannambath S, Moisan J, Stoop A, Battaglia S, Servattalab R, Hsu J, Bayliffe A, Katragadda M, Hayday AC. Vantourout P, et al. Sci Adv. 2023 Dec 8;9(49):eadj6174. doi: 10.1126/sciadv.adj6174. Epub 2023 Dec 6. Sci Adv. 2023. PMID: 38055824 Free PMC article. - Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.
Couturaud B, Doix B, Carretero-Iglesia L, Allard M, Pradervand S, Hebeisen M, Rufer N. Couturaud B, et al. Front Immunol. 2023 Nov 20;14:1293090. doi: 10.3389/fimmu.2023.1293090. eCollection 2023. Front Immunol. 2023. PMID: 38053994 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials